Same Indication

Ipilimumab vs Ondansetron

Ipilimumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between Ipilimumab and Ondansetron.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Ondansetron: Selective 5-HT3 receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Ondansetron — 3-5 hours.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O.

Molecular Weight: Ondansetron — 293.3660 g/mol.

Type: Ipilimumab — Antibody; Ondansetron — Small molecule.